Outcome-Linked Chronic Disease Management Software Development

Software that closes the gap between one visit and the next.

A patient with high blood pressure sees a clinician a few times a year and lives with the condition every other day. The readings, the missed refills, the skipped check-in text and the symptom that got worse on Tuesday all happen between visits, in systems that do not talk to each other and in front of nobody. The program enrolled the patient. Nobody owned what the numbers did next.

Cabot provides chronic disease management software development for health systems, medical groups, accountable care organizations and the digital health companies that serve them. We build the condition pathways, the monitoring and device data feeds, the patient self-management tools, the clinician worklists and the outcome reporting, along with the integration layer that connects them to your EHR. Where AI helps, such as summarizing a month of readings for a nurse, a person confirms the output before it reaches a patient.

Most engagements begin with a program audit of where patients fall out between visits and which measures nobody acts on, so you see the gap and what it costs before you commit to a build. Tell us which conditions you manage and what your EHR allows, and we will return a written scope with the integration questions that will decide your timeline.

‍

See the disease management systems we build See where AI fits and where it stops

No obligation. Your details stay private.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

6 in 10

adults in the United States have a chronic disease, and 4 in 10 have two or more.

22.5%

of US adults with hypertension have their blood pressure under control, based on national survey data from 2017 to 2020.

10 years

is the length of the CMS ACCESS model, which began in July 2026 and ties payment for chronic condition care to measurable patient outcomes.

What disease management software actually does between visits

Disease management software is the system that follows patients with a chronic condition between clinic visits, turns their readings and answers into tasks for a named person, and records the outcomes so a program can show whether patients are getting better.

Three terms get blurred. Disease management organizes care around one condition: the targets, the schedule, the monitoring and the escalation rules for diabetes, heart failure or depression. Care management organizes a team around one patient across conditions and settings, which we cover under care management software development. Remote monitoring is one input to both, the stream of readings from a device at home. A working program uses all three, and most packaged tools do one well and the others thinly.

The test for a leader is whether the system closes the loop or only collects data. An EHR will show a reading. It will not tell you which of eight hundred patients with uncontrolled readings has had no outreach in two weeks. Chronic disease management software development earns its cost in that second job. Where the work reaches into the wider record or integration engine, it sits with our healthcare software development practice.

Why chronic disease programs stall after enrollment

These are the six failure points program leaders describe once enrollment grows past what a spreadsheet and a few strong nurses can hold. None of them is fixed by asking clinicians to work harder.

Readings arrive and nobody owns them. A blood pressure or glucose reading lands in a dashboard, an inbox or a vendor portal. Without an assigned owner and a threshold, it waits until someone remembers to look, and the patient is seen again when the problem has become an admission.

Each condition runs in its own tool. A diabetes app, a heart failure monitor and a depression screen each hold part of the patient. Because 4 in 10 adults live with two or more chronic conditions, the patient who needs all three gets three programs and no single plan.

Alerts either flood the team or never fire. Thresholds set once by a vendor and never tuned produce noise, and a team that learns to ignore noise also ignores the alert that mattered.

Patients enroll and then drift away. Engagement is highest in the first weeks and falls after that. A reminder in the wrong channel, an app that needs a new password or a message pitched at the wrong reading level quietly ends the program for that patient.

Outcomes and billing evidence cannot be shown. Payers and Medicare now ask for control rates and patient-reported scores, while fee-for-service programs still need consent, time and documentation on record. When both are assembled by hand at month end, some work goes unclaimed and some results go unreported.

Packaged platforms do not fit the condition mix. A product built for one program design bends your pathway to match it, and it stalls when a payer contract adds a measure or an acquisition brings in a second EHR.

Clinical and administrative staff discussing hospital call handling and patient communication workflows (placeholder image, to be replaced)

The disease management systems we build and integrate

Six kinds of system, built to fit the EHR and the programs your teams already run rather than replacing them. Some organizations need all six over time. Most start with the condition where the control rate is furthest from target.

Around those six sit the modules specific programs ask for: caregiver access, consent controls for behavioral health records, and a handoff to a virtual visit when a reading crosses a line. Testing runs inside every increment, and our QA and testing practice handles load and regression testing as enrollment grows. The wider work of staying in touch between visits is covered under patient engagement solutions.

Condition pathways and care plans

A pathway for each condition you manage, such as diabetes, hypertension and heart disease, kidney disease, COPD and asthma, depression and anxiety, or chronic pain. Your clinicians set the targets, the schedule and the escalation rules, and a patient with two conditions gets one plan rather than two.

Remote monitoring and device data

Readings from blood pressure cuffs, glucometers, scales and wearables arrive in the same work queue as every other task, with thresholds your clinicians set and flags for readings that stop coming. See also our remote patient monitoring work.

Patient self-management and engagement

Reminders, education and check-ins reach patients by text, portal or app, in the language and reading level they use. We build against real adherence data, so a program that loses patients in week three shows it in week three.

Clinician worklists, triage and escalation

One worklist for the nurse, ordered by who is at risk and what is due, with a named owner for every alert and a timer on every escalation. A reading that crosses a line reaches a person, and a person who does not answer hands it to the next.

Outcome measurement, reporting and billing documentation

Blood pressure, A1c, weight, pain and depression scores captured as the work happens and reported against targets, with the consent, time and documentation that chronic care, principal care and remote monitoring billing require. The same records support quality and contract reporting for programs paid on outcomes.

Integration and support systems

The layer under everything else: EHR read and write, device data feeds, lab and pharmacy data, claims and health information exchange, and the patient matching that keeps one person from becoming two records. Outcome reporting draws on our health data analysis work.

What drives the cost of chronic disease management software?

Three things move the number: how many conditions the software has to manage, how deep the EHR and device data connections go, and how many patients, sites and care teams the rules have to cover. Device and EHR integration is the piece leaders most often underprice, so we cost it as a separate line. Start with a rough range from the calculator, then walk us through your programs and we will turn that range into a real estimate.

‍

Estimate your disease management software cost Ask us about your condition programs

How we find where patients are falling out between visits

Before we design anything we run a program audit that answers four questions, in order, because each one changes the build rather than the backlog. Most of the answers come from tracing a sample of real patients and sitting with a nurse through a working day.

Where patients fall out between visits

We follow a sample of enrolled patients from enrollment to the latest visit and mark every point where readings stopped, outreach stopped or nobody was assigned. The software has to be strongest there.

Which measures you track and who acts on them

For each condition we list the readings and scores you collect, then name the person who sees them and the threshold that makes that person act. Where the answer is nobody, that is the first workflow.

What your EHR and device data will expose

We establish which data each system and device vendor exposes, through which interfaces, and who approves access. In most projects, that answer decides the schedule.

How outcomes and program time are captured today

We look at how control rates, patient-reported scores and billing time reach a report or a claim. If the path runs through a spreadsheet, the first release has to replace it.

What does AI actually change for a nurse managing hundreds of patients?

Less than the marketing suggests, and more than a skeptic expects. The clearest win is reading. A nurse opening a patient's record faces a month of readings, a medication list and a pile of messages, and AI can turn them into a short brief of what changed and what is overdue. The second win is sorting: flagging readings that stopped coming, ordering the worklist by who is moving the wrong way, and drafting outreach messages from templates your clinicians have approved.

What AI should not do in a disease management program is decide. It does not change a medication, set or move a threshold, diagnose, or message a patient without approval. A clinician confirms every brief and every draft before it is used, and a clinician owns every rule. When the software is unsure, it says so and hands the case to a person. Where AI runs in the live product, we deploy it inside your compliance boundary on services covered by a business associate agreement. For the wider question of where AI belongs in your organization, our healthcare AI consulting team starts from your data and your governance.

The same discipline applies to how we build. Three commitments are written into every engagement. We stay model neutral, choosing the right tool for each task rather than tying your programs to one AI vendor. A named engineer reviews every AI assisted change before it merges and answers for it as for code they wrote themselves. And we never train models on your code or your data. During development, real patient data stays away from any model, and the records AI tests against are synthetic.

The tooling a Cabot build runs on

This kind of software succeeds or fails on its connections, so we pick the stack around your EHR, your device vendors and your hosting rather than around our preferences. Where your IT team has standardized on a cloud or a language, we build in it. The table below shows, stage by stage, what AI handles, what a person keeps, and which tools are involved.

What we work in:

Patient and clinician applications

React

React Native

TypeScript

Node.js

Python

SMS and push messaging

EHR and device data integration

HL7 v2

FHIR R4

SMART on FHIR

Device APIs

Bluetooth SDKs

PostgreSQL

Platform, security and quality

AWS

Azure

Terraform

Playwright

SonarQube

OpenTelemetry

What AI does at each stage of this kind of build, and what it never does

Every stage produces something you can review, and every stage has a person who signs it off. AI output does not enter your codebase, your records or your patients' messages until someone named has accepted it.

Build stage	What AI does	What stays human	Tools used
Program audit and scoping	Summarizes sample patient timelines and workflow notes into the decisions they contain, and drafts acceptance criteria from a written intent.	Sitting with nurses and clinicians, choosing the conditions and targets, setting the rules, and committing to scope.	Claude, Jira AI
Device and EHR integration build	Drafts message and device payload mappings, transformations and repetitive code, following patterns already in your repository.	The integration design, the data model, and every decision about which data crosses which boundary.	GitHub Copilot, Claude Code, Cursor
Code review	Flags a first round of problems such as unhandled errors, gaps in input validation and common security mistakes.	Approving the merge. One named engineer accepts each change and remains answerable for it.	GitHub Copilot, SonarQube
Test	Writes test cases against synthetic patient records, including missing readings, duplicate device messages and out of range values.	Choosing what must be tested, which failure would be clinically unacceptable, and whether the suite proves it.	Playwright, GitHub Copilot
Release and operate	Drafts release notes and groups production errors, such as rejected device messages, by likely cause.	The go or no-go call, the order conditions go live in, and how outcome data shapes the next increment.	GitHub Actions, Grafana

How a Cabot disease management build differs from a packaged platform

Packaged platforms work well when your conditions and workflow match the ones the product was designed around. These four dimensions are where the difference shows when they do not.

Dimension	Packaged platform	Cabot
How it fits your condition mix	Ships a fixed set of condition programs, so a condition or pathway it does not cover becomes a workaround.	Built around the conditions you manage, with pathways your clinicians can change when guidelines or contracts change.
How it connects to your EHR and devices	Supports the interfaces and device brands on its list, and anything else becomes a manual step or a custom project.	Integration is scoped against what your EHR and device vendors actually expose, with the workflow built around your teams.
What it costs as patients are enrolled	Often priced per patient per month or per device, so cost rises with every patient you enroll.	A build cost you can plan, with run costs that follow your infrastructure rather than your enrollment.
Who owns the outcome data and the roadmap	The vendor decides what is measured and what ships next, and exporting your history can become a project.	You own the code and the data, and the roadmap follows your outcome measures.

The organizations we build disease management software for

Three kinds of organization bring us this work. For each, here is what we have learned about how chronic disease programs actually break, not just a line saying we serve them. When program data must cross into systems outside your control, our healthcare interoperability team takes that part.

Health systems and medical groups running chronic programs

The pressure is control rates across thousands of patients with limited nursing time. The hard part is rarely the software. It is agreeing who owns a reading, how fast it must be acted on, and what happens when that person is out.

ACOs, payers and value-based organizations

Contracts and newer Medicare models reward measured outcomes, but the readings, claims and clinical records sit in different systems. The work is an outcome view a physician will accept, built on records that already exist.

Digital health and device companies building a condition program

A product team knows its condition and its users, and still needs clinical workflows, EHR connections and a compliance posture before a health system will adopt it. The work is reaching a pilot a health system can approve, then growing it in increments, the approach behind our MVP development services.

How patient data stays protected across every condition program

We treat security as a condition of finishing a feature, not a review scheduled at the end. Each user sees only the patients they are assigned, sign-in runs through single sign-on with multi-factor authentication, data is encrypted in transit and at rest, credentials live in a managed vault instead of in configuration files, and every time someone opens a record it is logged, starting with the first working version.

Compliance obligations are scoped to how your programs operate rather than applied wholesale. For this kind of software, that means HIPAA safeguards and a signed business associate agreement before any patient data moves, 42 CFR Part 2 handling where substance use disorder treatment records are involved, and data exchange designed with information blocking rules in mind. Some features, such as those that interpret readings to recommend treatment, may count as regulated device software. We raise that question early in design so your regulatory counsel can decide, and we keep the evidence trail that review needs. Our compliance practice covers the wider program.

Role-based access control

SSO and MFA

Encryption in transit and at rest

Audit logging of PHI access

HIPAA safeguards and BAA

42 CFR Part 2 handling

What happens, stage by stage, when we build a disease management system

The work runs in three stages, and each one closes with a choice that is yours to make. Many organizations commission the program audit on its own first, which lets them see how we work before they sign up for a build.

Program audit and scoping

We follow patients through your program from enrollment to the latest visit, measure where they drop, and establish what your EHR and device vendors expose and who approves access. The stage ends with a written scope, the targets and escalation rules your clinicians have agreed, and a realistic integration timeline. Whether to go further is then your call.

Build one condition pathway first, in reviewable increments

The first increment is the condition with the clearest gap between control and target. Each increment is something your nurses can use, tested against synthetic patients, and a named engineer approves every change before merge. After each increment, you choose what gets built next.

Go live by condition, measure and tune

Rollout goes condition by condition with an escalation path agreed in advance. After launch, thresholds, reminders and worklists are tuned against control rates and engagement data, including the times when a threshold matters more than a planned feature.

Who builds your system, and what each person answers for

Every role has a clear owner from day one. The tech lead answers for the architecture, the integration design and the decision to merge each change. An integration engineer looks after every connection into and out of your clinical systems and device feeds. Engineers carry their own pieces of work from start to finish. The quality lead answers for the test suite and for what it demonstrates. The delivery lead runs the schedule and keeps clinical leaders informed between demos. For any decision, you know the person responsible and how to reach them.

Our strength is concentrated in four areas. The first is the integration layer between device data, the EHR and a clinical workflow, where these projects most often lose time. The second is threshold and alert design, so that a nurse sees the reading that matters and not the hundred that do not. The third is capturing outcome measures and billing documentation without adding clicks to a clinician's day. The fourth is designing patient tools that people keep using after the first weeks. Where a packaged product would serve you better than a build, we say so.

Your team and ours work inside an overlap window agreed in writing at the start, and anything that needs your decision is saved for it. Design decisions live in your repository as short written records, so a change of engineer does not cost you weeks. If the scope grows, you can extend the existing team with more engineers rather than standing up a second one.

Why chronic care leaders choose Cabot for outcome-linked disease management software

A system like this only pays for itself if nurses work from it every day and the numbers it reports can be trusted. These are the reasons leaders give for bringing this work to Cabot.

The condition with the biggest gap goes first

We start with the condition furthest from its target, because it shows value soonest. Nurses work from it while later conditions are still being built, so the program improves as the build continues.

Pathways your clinicians can change

Targets, schedules, thresholds and escalation rules belong to your clinical team, and your own staff can adjust them when guidelines or contracts change. Where the work grows into a wider custom product, it runs through our healthcare application development team.

Outcomes captured as the work happens

Readings, scores and documentation are recorded inside the workflow, so control rates and the evidence behind a claim exist when a report is due and not after someone reconstructs them.

AI that summarizes, with a person who decides

Briefs and outreach drafts save nurses reading time, and a clinician approves every one before it is used. Your patient data is never used to train a model.

Integration risk surfaced in the first weeks

What your EHR and device vendors expose, who owns access and how long approval takes are established during the audit, not discovered halfway through the build.

Security and compliance from the first release

Access control, audit logging and encryption are part of the first working version, and the business associate agreement is signed before patient data moves.

Where to go next, depending on your situation

This page covers the conditions, the workflows and the connections between them. If one of these describes you better, start there instead.

You need home monitoring data inside the care plan

When readings arrive in a dashboard nobody opens, the fix is routing them into the work queue with thresholds clinicians set. Start at remote patient monitoring solutions.

Patients enroll and then stop engaging

When the program loses people after the first weeks, the problem is the experience between visits rather than the clinical pathway. Start at patient engagement solutions.

You run programs across a whole care team

When the challenge is who owns each patient across conditions and settings rather than one condition, the work is the team workflow. Start at care management software development.

Our Clients

Client Success Stories

AI-accelerated discovery-to-MVP patient and physician marketplace platform screenshot

AI-Accelerated Discovery to MVP for a HIPAA-Compliant Patient and Physician Marketplace

A discovery-to-MVP marketplace build that confirms every booking is license and location eligible before it happens, delivered inside a HIPAA boundary.

Read the case study

AI-Powered Referral Document Analyzer using Local LLMs

Referral documents extracted into structured fields by AI and confirmed by a person, running on locally hosted models rather than a third-party API.

Read the case study

Automated Patient Summary Generation and Eligibility Assessment

AI drafts a patient summary and eligibility assessment, and a coordinator confirms it before it is used.

Read the case study

MyHealingMate patient engagement platform screenshot

A Digital Platform Connecting Lives and Transforming Care

A HIPAA-compliant patient engagement platform pairing appointment scheduling with virtual consultations and medical record management, lifting virtual doctor consultations 15% in six months.

Read the case study

See all Cabot case studies

Questions healthcare leaders ask about disease management software

What is chronic disease management software development?
It is the design, build and integration of the software that follows patients with ongoing conditions between visits: condition pathways, monitoring and device data, patient self-management tools, clinician worklists, outcome reporting, and the connections to your EHR. It differs from buying a product because the workflows, thresholds and reports are built around the conditions and contracts you actually manage.
‍
How much does chronic disease management software development cost?
Price follows scope: how many conditions the software must manage, how deep the EHR and device integration goes, and how many patients, sites and teams the rules must cover. A per patient license tells you little about what a build will cost. Our cost calculator gives you a first range in a few minutes, and we then price it against your programs before anything is committed.
‍
Will a custom build connect to our EHR and to patient devices?
In most cases yes, and the real question is how. We establish what your EHR exposes, whether through HL7 v2 messages, FHIR APIs or vendor interfaces, what each device vendor offers, whether a direct API, a cloud feed or an aggregator, and whose sign-off is needed to use them. We settle that during the audit, so the integration timeline you receive reflects your environment rather than a brochure.
‍
Which Medicare programs and payment models can the software support?
It can capture the enrollment, consent, time and documentation that chronic care, principal care, advanced primary care and remote patient monitoring billing require, along with the outcome measures that models paying on results ask for. The 2026 physician fee schedule added shorter period remote monitoring codes and behavioral health add-ons to the advanced primary care codes, and the CMS ACCESS model, which began in July 2026, pays for chronic condition care based on measured outcomes. Your billing and compliance team confirms what you may claim, and we build the workflow to produce the evidence.
‍
Should we buy a disease management platform or build our own?
Buy when a packaged platform fits your conditions and your EHR with light configuration, because it will be faster and cheaper. Build or extend when your pathways, payer contracts or integrations fall outside what products support, or when you need to own the data and the roadmap. We tell you which applies after the audit, including when the answer is to buy.
‍
How long does it take to build disease management software?
The first condition pathway is the fastest part to reach your nurses. The full timeline is set less by the build than by data access: which interfaces and device feeds exist, who owns the test environment, and how long approval takes. We establish all three during the audit, so the timeline you receive reflects them rather than a generic estimate.
‍
Is a custom disease management platform HIPAA compliant, and who carries the risk?
Compliance is shared, not transferred. Under a business associate agreement we are accountable for the protections inside what we build and operate: who can open a record, how it is encrypted, how every access is logged, and the evidence that those controls work. Your organization remains the covered entity, and we set out in writing which obligations stay with you, including 42 CFR Part 2 where it applies. We also raise early any feature that may count as regulated device software, so your regulatory counsel can decide.
‍
Can AI be used in disease management software, and who decides?
Yes, for reading and sorting, never for deciding. AI can summarize a month of readings into a brief for a nurse, flag readings that stopped coming, and draft outreach from messages your clinicians approved. A clinician confirms every output before it is used and owns every rule and threshold. We never train models on your data, and we stay model neutral.